Beranda › Sklerosis Multipel › North Carolina
Uji klinis Sklerosis Multipel di North Carolina
8 studi untuk Sklerosis Multipel mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 101, Raleigh
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Charlotte
- TG Therapeutics Investigational Trial Site, New Bern
- TG Therapeutics Investigational Trial Site, Raleigh
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Duke University, Durham
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07477639A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
- BRIUMVI® Pregnancy Registry Virtual Research Coordination Center, Wilmington
Menerima pesertaStudi observasional
Usia 15 hingga 50 · Wanita · Diperbarui 21 Sep 2026 · NCT06433765RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of North Carolina at Chapel Hill, Chapel Hill
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002, Charlotte
- Raleigh Neurology Associates- Site Number : 8400014, Raleigh
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07325292Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- IQVIA US Office, Durham
Menerima pesertaStudi observasional
Semua usia · Wanita · Diperbarui 11 Agu 2026 · NCT05658497Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT03233646Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.